1
FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS
Condition(s):Renal Cell Carcinoma (RCC)Last Updated:May 21, 2019Active, not recruiting
Renal Cell Carcinoma: 1842 Clinical Trials, Page 1 of 185
Hide Studies Not Open or Pending
2
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.
Condition(s):Renal Cell Carcinoma; Progression; Lymphocyte Disorder; Monocytosis; Local DiseaseLast Updated:January 2, 2020Recruiting
3
Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)
Condition(s):Kidney CancerLast Updated:January 10, 2020Recruiting
4
CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:April 22, 2019Completed
5
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Condition(s):Hepatitis C; Renal Cell Carcinoma; Colorectal CancerLast Updated:September 17, 2014Completed
6
Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:July 9, 2019Active, not recruiting
7
Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:February 6, 2014Completed
8
Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:September 18, 2019Completed
9
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:January 15, 2019Recruiting
10
PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:December 5, 2019Not yet recruiting